Merck, CR UK, ICR collaborate on cancer drug discovery
admin 17th January 2018 Uncategorised 0Cancer Research UK’s Commercial Partnerships Team and The Institute of Cancer Research, London, have entered into a multi-project collaboration and licensing deal with Germany’s Merck to discover and develop new anticancer therapies.
More: Merck, CR UK, ICR collaborate on cancer drug discovery
Source: News